Roche Inks $3.4 Billion Deal to Acquire Ventana | GenomeWeb
NEW YORK (GenomeWeb News) — Nearly seven months after its initial $3 billion bid to acquire Ventana Medical Systems was rebuffed by that company’s board of directors, Roche today announced that it has signed a definitive merger agreement with Ventana valued at roughly $3.4 billion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.